Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro

Effective chemotherapeutic strategies for uterine sarcoma are lacking; existing therapies achieve poor response rates. Previous studies have identified the prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) as a potential anticancer treatment; however, its effectiveness in uterine sarcoma has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakita, Takako, Masato, Nisimura, Takiguchi, Eri, Abe, Akiko, Irahara, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450749/
https://www.ncbi.nlm.nih.gov/pubmed/28587364
http://dx.doi.org/10.3892/etm.2017.4346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450749/
https://www.ncbi.nlm.nih.gov/pubmed/28587364
http://dx.doi.org/10.3892/etm.2017.4346

Ejemplares similares